Life ScienceCompany
Saol Therapeutics M&A Summary
Saol Therapeutics has acquired 1 company of its own. It has also divested 1 asset.
Saol Therapeutics’ largest acquisition to date was in 2017, when it acquired Aptevo Therapeutics - Hyperimmune Commercial Products for $75M. Saol Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include medical products (100%).
Saol Therapeutics Ownership
Who owns Saol Therapeutics?
Saol Therapeutics is owned by Avego Healthcare Capital and DFW Capital Partners. It was acquired on January 2, 2017.
Is Saol Therapeutics PE-backed?
Yes. Saol Therapeutics is owned by private equity investors Avego Healthcare Capital and DFW Capital Partners.
Saol Therapeutics Business Overview
Where is Saol Therapeutics headquartered?
Saol Therapeutics is headquartered in Roswell, Georgia.
What sector is Saol Therapeutics in?
Saol Therapeutics is a life science company.
When was Saol Therapeutics founded?
Saol Therapeutics was founded in 2015.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1